Acorda Therapeutics Inc Ret. sur l'équité
Quel est le Ret. sur l'équité de Acorda Therapeutics Inc?
Le Ret. sur l'équité de Acorda Therapeutics Inc est -2,206.93%
Quelle est la définition de Ret. sur l'équité?
Le rendement des capitaux propres est une mesure de la rentabilité d'une entreprise par rapport à la valeur comptable des capitaux propres. Il est calculé en divisant le résultat net de l'exercice par le total des capitaux propres.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. sur l'équité des entreprises dans Health Care secteur sur NASDAQ par rapport à Acorda Therapeutics Inc
Que fait Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Entreprises avec ret. sur l'équité similaire à Acorda Therapeutics Inc
- Nevada Zinc a Ret. sur l'équité de -2,432.45%
- Beijing Digital Telecom Co a Ret. sur l'équité de -2,335.71%
- Frankly a Ret. sur l'équité de -2,318.05%
- Immunocellular Therapeutics Ltd a Ret. sur l'équité de -2,312.00%
- Magnis Resources a Ret. sur l'équité de -2,273.33%
- Differ a Ret. sur l'équité de -2,210.36%
- Acorda Therapeutics Inc a Ret. sur l'équité de -2,206.93%
- Fortinet Inc a Ret. sur l'équité de -2,201.01%
- Parallel Mining a Ret. sur l'équité de -2,194.42%
- Akazoo S.A a Ret. sur l'équité de -2,138.46%
- Maxeon Solar Technologies a Ret. sur l'équité de -2,116.93%
- Remark a Ret. sur l'équité de -2,109.50%
- Godaddy Inc a Ret. sur l'équité de -2,094.54%